J
Johanna Zerbib
Researcher at Tel Aviv University
Publications - 7
Citations - 163
Johanna Zerbib is an academic researcher from Tel Aviv University. The author has contributed to research in topics: Gene & Cancer. The author has an hindex of 3, co-authored 4 publications receiving 40 citations.
Papers
More filters
Journal ArticleDOI
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition
Yael Cohen-Sharir,James M. McFarland,Mai Abdusamad,Carolyn Marquis,Sara Vanessa Bernhard,Mariya Kazachkova,Helen Tang,Marica Rosaria Ippolito,Kathrin Laue,Johanna Zerbib,Heidi L.H. Malaby,Andrew Jones,Lisa-Marie Stautmeister,Irena Bockaj,René Wardenaar,Nicholas J. Lyons,Ankur K. Nagaraja,Ankur K. Nagaraja,Adam J. Bass,Adam J. Bass,Diana C.J. Spierings,Floris Foijer,Rameen Beroukhim,Rameen Beroukhim,Stefano Santaguida,Stefano Santaguida,Todd R. Golub,Todd R. Golub,Jason Stumpff,Zuzana Storchova,Uri Ben-David +30 more
TL;DR: In this paper, aneuploid cancer cells exhibited aberrant spindle geometry and dynamics, and kept dividing when the SAC was inhibited, resulting in the accumulation of mitotic defects, and in unstable and less-fit karyotypes.
Journal ArticleDOI
Gene copy-number changes and chromosomal instability induced by aneuploidy confer resistance to chemotherapy.
Marica Rosaria Ippolito,Valentino Martis,Sara Martin,Andréa E. Tijhuis,Christy Hong,René Wardenaar,Marie Dumont,Johanna Zerbib,Diana C.J. Spierings,Daniele Fachinetti,Uri Ben-David,Floris Foijer,Stefano Santaguida,Stefano Santaguida +13 more
TL;DR: In this paper, the authors show that cancer cells might exploit aneuploidy-induced genome instability and the resulting gene copy-number changes to survive under conditions of selective pressure, such as chemotherapy.
Posted ContentDOI
Aneuploidy-driven genome instability triggers resistance to chemotherapy
Marica Rosaria Ippolito,Valentino Martis,Christy Hong,René Wardenaar,Johanna Zerbib,Diana C.J. Spierings,Uri Ben-David,Floris Foijer,Stefano Santaguida,Stefano Santaguida +9 more
TL;DR: It is shown that cancer cells might exploit aneuploidy-induced genome instability to survive under conditions of selective pressure, such as chemotherapy, and might explain why some chemotherapies fail to succeed.
Posted ContentDOI
Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage
Johanna Zerbib,Marica Rosaria Ippolito,Yonatan Eliezer,Giuseppina De Feudis,Eli Reuveni,Anouk Savir Kadmon,Sara Martin,S. Vigano,Gil Leor,James Berstler,Kathrin Laue,Yael Cohen-Sharir,Simone Scorzoni,Francisca Vazquez,Uri Ben-David,Stefano Santaguida +15 more
TL;DR: In this paper , aneuploidy was induced in non-transformed RPE1-hTERT cells and derived multiple stable clones with various degrees of chromosome imbalances.
Journal ArticleDOI
Aneuploidy-Driven Genome Instability Triggers Resistance to Chemotherapy
Marica Rosaria Ippolito,Valentino Martis,Christy Hong,René Wardenaar,Johanna Zerbib,Diana C.J. Spierings,Uri Ben-David,Floris Foijer,Stefano Santaguida +8 more
TL;DR: It is shown that cancer cells might exploit aneuploidy-induced genome instability to survive under conditions of selective pressure, such as chemotherapy, and might explain why some chemotherapies fail to succeed.